Translations:Paricalcitol/1/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 445909355 | IUPAC_name = (1''R'',3''R'',7''E'',17β)-17-[(1''R'',2''E'',4''S'')-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol | image = Paricalcitol.svg | width = 200px | image2 = Paricalcitol3Dan.gif | width2 = 200px <!--Clinical data--> | tradename = Zemplar | Drugs.com = {{drugs.com|monograph|paricalcitol}} | MedlinePlus = a682335 | pregnancy_AU = C | pregnanc..."
 
(No difference)

Latest revision as of 23:14, 12 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Paricalcitol)
{{short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 445909355
| IUPAC_name = (1''R'',3''R'',7''E'',17β)-17-[(1''R'',2''E'',4''S'')-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol
| image = Paricalcitol.svg
| width = 200px
| image2 = Paricalcitol3Dan.gif
| width2 = 200px
<!--Clinical data-->
| tradename =  Zemplar
| Drugs.com = {{drugs.com|monograph|paricalcitol}}
| MedlinePlus = a682335
| pregnancy_AU = C
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = Oral, Intravenous
<!--Pharmacokinetic data-->
| bioavailability = 72%
| protein_bound = 99.8%
| metabolism = [[Hepatic]]
| elimination_half-life = 14-20 hours
| excretion = Faeces (74%), urine (16%)
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 131918-61-1
| ATC_prefix = H05
| ATC_suffix = BX02
| ATC_supplemental =  
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 7931
| PubChem = 5281104
| IUPHAR_ligand = 2791
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00910
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4444552
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6702D36OG5
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00930
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1200622
<!--Chemical data-->
| chemical_formula =
| C=27 | H=44 | O=3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BPKAHTKRCLCHEA-UBFJEZKGSA-N
| synonyms = <small>(1''R'',3''S'')-5-[2-[(1''R'',3a''R'',7a''S'')-1-<nowiki>[</nowiki>(2''R'',5''S'')-6-hydroxy-5,6-dimethyl-3''E''-hepten-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-cyclohexane-1,3-diol</small>
}}
Paricalcitol/1/ja
Clinical data
Trade namesZemplar
Other names(1R,3S)-5-[2-[(1R,3aR,7aS)-1-[(2R,5S)-6-hydroxy-5,6-dimethyl-3E-hepten-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-cyclohexane-1,3-diol
AHFS/Drugs.comMonograph
MedlinePlusa682335
Pregnancy
category
  • AU: C
Routes of
administration		Oral, Intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability72%
Protein binding99.8%
MetabolismHepatic
Elimination half-life14-20 hours
ExcretionFaeces (74%), urine (16%)
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC27H44O3
Molar mass416.646 g·mol−1
 ☒NcheckY (what is this?)  (verify)
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Paricalcitol/1/ja&oldid=138594"